We are live on ! Find out more
CFO

CVA Family Office Portfolio holdings

AUM $950M
1-Year Est. Return 20.72%
This Fund
S&P 500
This Quarter Est. Return
+0.52%
1 Year Est. Return
+20.72%
3 Year Est. Return
+57.41%
5 Year Est. Return
+58.71%
10 Year Est. Return
AUM
$950M
AUM Growth
+$80.2M
Cap. Flow
+$86.7M
Cap. Flow %
9.12%
Top 10 Hldgs %
37.72%
Holding
1,882
New
594
Increased
847
Reduced
129
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 7.62%
2 Financials 3.86%
3 Communication Services 2.37%
4 Industrials 2.2%
5 Healthcare 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FND icon
1601
Floor & Decor
FND
$5.81B
$1.32K ﹤0.01%
26
+18
+225% +$1.17K
CTRE icon
1602
CareTrust REIT
CTRE
$10.2B
$1.32K ﹤0.01%
36
CNO icon
1603
CNO Financial Group
CNO
$4.97B
$1.31K ﹤0.01%
32
CSW
1604
CSW Industrials
CSW
$4.71B
$1.3K ﹤0.01%
+5
New +$1.45K
DXC icon
1605
DXC Technology
DXC
$1.63B
$1.29K ﹤0.01%
103
+62
+151% +$832
GLOB icon
1606
Globant
GLOB
$1.35B
$1.29K ﹤0.01%
+28
New +$1.55K
VSEC icon
1607
VSE Corp
VSEC
$5.48B
$1.29K ﹤0.01%
+7
New +$1.43K
LYG icon
1608
Lloyds Banking Group
LYG
$87.4B
$1.28K ﹤0.01%
255
OPRA
1609
Opera Ltd
OPRA
$1.65B
$1.28K ﹤0.01%
90
UAA icon
1610
Under Armour
UAA
$3B
$1.28K ﹤0.01%
+217
New +$1.41K
IPAR icon
1611
Interparfums
IPAR
$3.92B
$1.27K ﹤0.01%
+14
New +$1.33K
ICL icon
1612
ICL Group
ICL
$6.81B
$1.27K ﹤0.01%
246
LAMR icon
1613
Lamar Advertising Co
LAMR
$16.2B
$1.27K ﹤0.01%
10
PSO icon
1614
Pearson
PSO
$9.78B
$1.26K ﹤0.01%
96
CYTK icon
1615
Cytokinetics
CYTK
$11B
$1.25K ﹤0.01%
+19
New +$1.21K
FBK icon
1616
FB Financial Corp
FBK
$2.95B
$1.25K ﹤0.01%
+24
New +$1.35K
TOWN icon
1617
Towne Bank
TOWN
$3.35B
$1.25K ﹤0.01%
+37
New +$1.28K
YELP icon
1618
Yelp
YELP
$1.38B
$1.24K ﹤0.01%
+50
New +$1.27K
TLX
1619
Telix Pharmaceuticals
TLX
$3.46B
$1.22K ﹤0.01%
+127
New +$967
CWEN.A
1620
DELISTED
Clearway Energy Class A
CWEN.A
$1.21K ﹤0.01%
+31
New +$1.1K
DNLI icon
1621
Denali Therapeutics
DNLI
$3.67B
$1.21K ﹤0.01%
+63
New +$1.25K
UUUU icon
1622
Energy Fuels
UUUU
$2.82B
$1.21K ﹤0.01%
+66
New +$1.37K
CCC
1623
CCC Intelligent Solutions
CCC
$3.42B
$1.2K ﹤0.01%
+200
New +$1.31K
LGND icon
1624
Ligand Pharmaceuticals
LGND
$6.02B
$1.2K ﹤0.01%
+6
New +$1.19K
IRTC icon
1625
iRhythm Holdings
IRTC
$3.59B
$1.18K ﹤0.01%
10

Similar funds

CVA Family Office's Q1 2026 Portfolio in Review

As of Q1 2026, CVA Family Office held 1,882 positions worth $950M, up 9.2% from $869M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

CVA Family Office deployed $86.7M of net new capital in Q1 2026, opening 594 new positions and adding to 847 existing holdings. Its largest new stake was iShares iBonds Dec 2032 Term Corporate ETF: 9,700 shares worth $245K.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, down from 8.1% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $4.89M trimmed.

  • CVA Family Office's largest Q1 2026 buy was iShares iBonds Dec 2032 Term Corporate ETF: 9,700 shares worth $245K.
  • CVA Family Office added most to Dimensional US Core Equity Market ETF in Q1 2026, an estimated $8.53M increase.
  • CVA Family Office's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $4.89M.
  • CVA Family Office fully exited Diageo in Q1 2026, selling an estimated $95.8K.
  • CVA Family Office's ten largest holdings make up 38% of its $950M portfolio in Q1 2026.
  • CVA Family Office opened 594 new positions and closed 44 in Q1 2026.
  • CVA Family Office's portfolio value rose 9.2% quarter-over-quarter to $950M.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.